The role of cadherin/catenin complex in malignant melanoma

Experimental Oncology

Volumn 28, Issue 3, 2006, Pages 187-193

  Bonitsis, N ^a   Batistatou, A ^a   Karantima, S ^a   Charalabopoulos, K ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Adhesion molecules; Cadherins; Catenins; Dysadherin; Melanoma

Indexed keywords

CADHERIN; CATENIN; CELL ADHESION MOLECULE; DYSADHERIN; MEMBRANE PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEIN P CADHERIN; UNCLASSIFIED DRUG; UVOMORULIN; VASCULAR ENDOTHELIAL CADHERIN;

CANCER CELL; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; COMPLEX FORMATION; DOWN REGULATION; GENE SILENCING; HUMAN; MELANOCYTE; MELANOMA; METASTASIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; REVIEW;

CADHERINS; CATENINS; HUMANS; MELANOMA; SKIN NEOPLASMS;

EID: 33750940371     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Klymkowsky MW, Parr B. The body language of cells: the intimate connection between cell adhesion and behavior. Cell 1995; 83: 5-8.
2. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 2003; 22: 2318-23.
3. Charalabopoulos K, Binolis J, Karkabounas S. Adhesion molecules in carcinogenesis. Exp Oncol 2002; 24: 249-57.
4. Furukawa F, Fujii K, Horiguchi Y, Matsuyoshi N, Fujita M, Toda K, Imamura S, Wakita H, Shirahama S, Takigawa M. Roles of E- and P-cadherin in the human skin. Microsc Res Tech 1997; 38: 343-52.
5. Smith SH, Goldschmidt MH, McManus PM. A comparative review of melanocytic neoplasms. Vet Pathol; 39: 651-78.
6. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 1991; 251: 1451-5.
7. Hendrix MJ, Seftor EA, Meltzer PS, Gardner LM, Hess AR, Kirschmann DA, Schatteman GC, Seftor RE. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A 2001; 98: 8018-23.
8. Krengel S, Groteluschen F, Bartsch S, Tronnier M. Cadherin expression pattern in melanocytic tumors more likely depends on the melanocyte environment than on tumor cell progression. J Cutan Pathol 2004; 31: 1-7.
9. Ozawa M, Kemler R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol 1992; 116: 989-96.
10. Tang A, Eller MS, Hara M, Yaar M, Hirohashi S, Gilchrest BA. E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro. J Cell Sci 1994; 107: 983-92.
11. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85.
12. Yap AS, Brieher WM, Gumbiner BM. Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 1997; 13: 119-46.
13. Zhang XD, Hersey P. Expression of catenins and p120cas in melanocytic nevi and cutaneous melanoma: deficient alpha-catenin expression is associated with melanoma progression. Pathology 1999; 31: 239-46.
14. Sanders DS, Blessing K, Hassan GA, Bruton R, Marsden JR, Jankowski J. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol Pathol 1999; 52: 151-7.
15. Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM, Vernon SW, Cronin K, Edwards BK. The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer. Cancer 2000; 88: 2398-424.
16. Bar-Eli M. Molecular mechanisms of melanoma metastasis. J Cell Physiol 1997; 173: 275-8.
17. Luca MR, Bar-Eli M. Molecular changes in human melanoma metastasis. Histol Histopathol 1998; 13: 1225-31.
18. Clark WH Jr, Elder DE, Guerry D 4th, Epstein MN, Greene MH, Van Horn M. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984; 15: 1147-65.
19. Dixon PM, Head KW. Equine nasal and paranasal sinus tumours: part 2: a contribution of 28 case reports. Vet J 1999; 157: 279-94.
20. Meleo KA. Tumors of the skin and associated structures. Vet Clin North Am Small Anim Pract 1997; 27: 73-94.
21. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
22. Fitzpatrick TB, Szabo G, Seizi M, Quevedo WC Jr. Biology of the melanoma pigmentary system. In: Dermatology in General Medicine. Fitzpatrick TB, Eisen A, Wolf K, Freedberg I, Austen KC, eds. New York: Mc Graw-Hill, 1979; p. 131-45.
23. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001; 1: 46-54.
24. Nakagawa S, Takeichi M. Neural crest emigration from the neural tube depends on regulated cadherin expression. Development 1998; 125: 2963-7.
25. Haass NK, Herlyn M. Normal human melanocyte homeostasis as a paradigm for understanding melanoma. J Investig Dermatol Symp Proc 2005; 10: 153-63.
26. Haass NK, Smalley KS, Li L, Herlyn M. Adhesion, migration and communication in melanocytes and melanoma. Pigment Cell Res 2005; 18: 150-9.
27. Hsu MY, Wheelock MJ, Johnson KR, Herlyn M. Shifts in cadherin profiles between human normal melanocytes and melanomas. J Investig Dermatol Symp Proc 1996; 1: 188-94.
28. Gruss C, Herlyn M. Role of cadherins and matrixins in melanoma. Curr Opin Oncol 2001; 13: 117-23.
29. Voura EB, Sandig M, Siu CH. Cell-cell interactions during transendothelial migration of tumor cells. Microsc Res Tech 1998; 43: 265-75.
30. Fidler IJ. Biology of melanoma metastasis. In: Cutaneous Melanoma. Bach CM, Houghton AN, Soberr AJ, Soong S, eds. Quality Medical Publishing, 1998; p. 493-516.
31. Hsu M, Andl T, Li G, Meinkoth JL, Herlyn M. Cadherin repertoire determines partner-specific gap junctional communication during melanoma progression. J Cell Sci 2000; 113: 1535-42.
32. Ruiter DJ, van Muijen GN. Markers of melanocytic tumour progression. J Pathol 1998; 186: 340-2.
33. Gumbiner BM, McCrea PD. Catenins as mediators of the cytoplasmic functions of cadherins. J Cell Sci Suppl 1993; 17: 155-8.
34. Bracke ME, Van Roy FM, Mareel MM. The E-cadherin/catenin complex in invasion and metastasis. Curr Top Microbiol Immunol 1996; 213: 123-61.
35. Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle P, Elder DE, Herlyn M. E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 2000; 156: 1515-25.
36. Horiguchi Y, Furukawa F, Fujita M, Imamura S. Ultrastructural localization of E-cadherin cell adhesion molecule on the cytoplasmic membrane of keratinocytes in vivo and in vitro. J Histochem Cytochem 1994; 42: 1333-40.
37. Matsuyoshi N, Tanaka T, Toda K, Imamura S. Identification of novel cadherins expressed in human melanoma cells. J Invest Dermatol 1997; 108: 908-13.
38. Dorudi S, Sheffield JP, Poulsom R, Northover JM, Hart IR. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 1993; 142: 981-6.
39. Behrens J, Mareel MM, Van Roy FM, Birchmeier W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 1989; 108: 2435-47.
40. Cowley GP, Smith ME. Cadherin expression in melanocytic naevi and malignant melanomas. J Pathol 1996; 179: 183-7.
41. Shirahama S, Furukawa F, Wakita H, Takigawa M. E- and P-cadherin expression in tumor tissues and soluble E-cadherin levels in sera of patients with skin cancer. J Dermatol Sci 1996; 13: 30-6.
42. Katayama M, Hirai S, Kamihagi K, Nakagawa K, Yasumoto M, Kato I. Soluble E-cadherin fragments increased in circulation of cancer patients. Br J Cancer 1994; 69: 580-5.
43. Meier F, Nesbit M, Hsu MY, Martin B, Van Belle P, Elder DE, Schaumburg-Lever G, Garbe C, Walz TM, Donatien P, Crombleholme TM, Herlyn M. Human melanoma progression in skin reconstructs: biological significance of bFGF. Am J Pathol 2000; 156: 193-200.
44. Poser I, Dominguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001; 276: 24661-6.
45. Nyormoi O, Bar-Eli M. Transcriptional regulation of metastasis-related genes in human melanoma. Clin Exp Metastasis 2003; 20: 251-63.
46. Seline PC, Norris DA, Horikawa T, Fujita M, Middleton MH, Morelli JG. Expression of E and P-cadherin by melanoma cells decreases in progressive melanomas and following ultraviolet radiation. J Invest Dermatol 1996; 106: 1320-4.
47. Silye R, Karayiannakis AJ, Syrigos KN, Poole S, van Noorden S, Batchelor W, Regele H, Sega W, Boesmueller H, Krausz T, Pignatelli M. E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 1998; 186: 350-5.
48. Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 1999; 18: 345-57.
49. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-66.
50. Andersen K, Nesland JM, Holm R, Florenes VA, Fodstad O, Maelandsmo GM. Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma. Mod Pathol 2004; 17: 990-7.
51. Danen EH, de Vries TJ, Morandini R, Ghanem GG, Ruiter DJ, van Muijen GN. E-cadherin expression in human melanoma. Melanoma Res 1996; 6: 127-31.
52. McGary EC, Lev DC, Bar-Eli M. Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biol Ther 2002; 1: 459-65.
53. Tsutsumida A, Hamada J, Tada M, Aoyama T, Furuuchi K, Kawai Y, Yamamoto Y, Sugihara T, Moriuchi T. Epigenetic silencing of E- and P-cadherin gene expression in human melanoma cell lines. Int J Oncol 2004; 25: 1415-21.
54. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeier W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991; 113: 173-85.
55. Moll R, Mitze M, Frixen UH, Birchmeier W. Differential loss of E-cadherin expression in infiltrating ductal and tabular breast carcinomas. Am J Pathol 1993; 143: 1731-42.
56. Siitonen SM, Kononen JT, Helin HJ, Rantala IS, Holli KA, Isola JJ. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. Am J Clin Pathol 1996; 105: 394-402.
57. Kuphal S, Bosserhoff AK. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene 2006; 25: 248-59.
58. Nishizawa A, Nakanishi Y, Yoshimura K, Sasajima Y, Yamazaki N, Yamamoto A, Hanada K, Kanai Y, Hirohashi S. Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients. Cancer 2005; 103: 1693-700.
59. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24: 73-6.
60. Birchmeier W, Weidner KM, Hulsken J, Behrens J. Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 1993; 4: 231-9.
61. Jouneau A, Yu YQ, Pasdar M, Larue L. Plasticity of cadherin-catenin expression in the melanocyte lineage. Pigment Cell Res 2000; 13: 260-72.
62. Li G, Herlyn M. Dynamics of intercellular communication during melanoma development. Mol Med Today 2000; 6: 163-9.
63. Li G, Satyamoorthy K, Herlyn M. Dynamics of cell interactions and communications during melanoma development. Crit Rev Oral Biol Med 2002; 13: 62-70.
64. Li G, Satyamoorthy K, Herlyn M. N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 2001; 61: 3819-25.
65. Ciolczyk-Wierzbicka D, Amoresano A, Casbarra A, Hoja-Lukowicz D, Litynska A, Laidler P. The structure of the oligosaccharides of N-cadherin from human melanoma cell lines. Glycoconj J 2004; 20: 483-92.
66. Qi J, Chen N, Wang J, Siu CH. Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 2005; 16: 4386-97.
67. Fujita M, Furukawa F, Fujii K, Horiguchi Y, Takeichi M, Imamura S. Expression of cadherin cell adhesion molecules during human skin development: morphogenesis of epidermis, hairfollicles and eccrine sweat ducts. Arch Dermatol Res 1992; 284: 159-66.
68. Bauer R, Hein R, Bosserhoff AK. A secreted form of P-cadherin is expressed in malignant melanoma. Exp Cell Res 2005; 305: 418-26.
69. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11: 8606-14.
70. Van Marck V, Stove C, Van Den Bossche K, Stove V, Paredes J, Vander Haeghen Y, Bracke M. P-cadherin promotes cell-cell adhesion and counteracts invasion in human melanoma. Cancer Res 2005; 65: 8774-83.
71. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-57.
72. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J Clin Invest 1996; 98: 1949-53.
73. Hess AR, Seftor EA, Gardner LM, Carles-Kinch K, Schneider GB, Seftor RE, Kinch MS, Hendrix MJ. Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2). Cancer Res 2001; 61: 3250-5.
74. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Molecular plasticity of human melanoma cells. Oncogene 2003; 22: 3070-5.
75. Ino Y, Gotoh M, Sakamoto M, Tsukagoshi K, Hirohashi S. Dysadherin, a cancer-associated cell membrane glycoprotein, down-regulates E-cadherin and promotes metastasis. Proc Natl Acad Sci U S A 2002; 99: 365-70.
76. Batistatou A, Charalabopuolos A, Scopa C, Nakanishi Y, Kappas A, Hirohashi S, Agnantis NJ, Charalabopoulos K. Expression patterns of dysadherin and E-cadherin in lymph node metastases of colorectal carcinoma. Virch Arch 2006; 448: 763-7.
77. Kyzas P, Stefanou D, Batistatou A, Agnantis NJ, Nakanishi Y, Hirohashi S, Charalabopoulos K. Dysadherin expression in head and neck squamous cell carcinoma: association with lymphangiogenesis and prognostic significance. Am J Surg Pathol 2006; 30: 185-93.
78. Batistatou A, Scopa C, Ravazoula P, Nakanishi Y, Peschos D, Agnantis NJ, Hirohashi S, Charalabopoulos K. Involvement of dysadherin and E-cadherin in the development of testicular tumors. Br J Cancer 2005; 93: 1382-7.